Heinz-Otto Peitgen
Directeur/Membre du Conseil chez Jacobs University Bremen
Profil
Heinz-Otto Peitgen is the founder of MeVis Medical Solutions AG, which was founded in 1997.
He is currently the Director at the University of Graz, a Non-Executive Director at Brainomix Ltd., a Member-Governors Board at Jacobs University Bremen, a Professor at the University of Bremen, and a Trustee at Zentrum für Kunst und Medientechnologie and Stiftung Bremer Wertpapierbörse.
Postes actifs de Heinz-Otto Peitgen
| Sociétés | Poste | Début |
|---|---|---|
| Jacobs University Bremen | Directeur/Membre du Conseil | 01/01/2013 |
| Zentrum für Kunst und Medientechnologie | Directeur/Membre du Conseil | 01/01/2002 |
| University of Bremen | Corporate Officer/Principal | 01/01/1977 |
| University of Graz | Directeur/Membre du Conseil | 01/01/2003 |
| Stiftung Bremer Wertpapierbörse | Directeur/Membre du Conseil | - |
Brainomix Ltd.
 Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | 12/10/2020 |
Anciens postes connus de Heinz-Otto Peitgen
| Sociétés | Poste | Fin |
|---|---|---|
| MEVIS MEDICAL SOLUTIONS AG | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEVIS MEDICAL SOLUTIONS AG | Technology Services |
| Entreprise privées | 3 |
|---|---|
| Zentrum für Kunst und Medientechnologie | |
| Stiftung Bremer Wertpapierbörse | |
Brainomix Ltd.
Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Health Technology |
